Lysis and covered endovascular reconstruction of the aortic bifurcation (LA CERAB) technique for chronic juxtarenal aortic occlusions.

IF 1.4 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of Cardiovascular Surgery Pub Date : 2023-08-01 DOI:10.23736/S0021-9509.23.12685-1
David J Minion
{"title":"Lysis and covered endovascular reconstruction of the aortic bifurcation (LA CERAB) technique for chronic juxtarenal aortic occlusions.","authors":"David J Minion","doi":"10.23736/S0021-9509.23.12685-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study was to review early experience with catheter directed thrombolysis in the setting of chronic juxtarenal aortic occlusion as an initial therapy to allow safe definitive management with placement of aorto-iliac endografts.</p><p><strong>Methods: </strong>A retrospective review was performed of all patients with a diagnosis of chronic juxtarenal aortic occlusion treated by the author with initial catheter directed thrombolysis. In all, six patients (five males and one female, average age of 57 years) treated between 2019 and 2022 met criteria. Total duration of symptoms prior to thrombolysis ranged from 2 to 54 months (average 23 months.) Four patients (67%) had progressed to tissue loss 2 to 5 months prior to the initiation of thrombolysis (average 3.25 months). Radiographic confirmation of aortic occlusion on preoperative imaging was noted 7 to 846 days prior to the initiation of thrombolysis (average 190 days).</p><p><strong>Results: </strong>Five of six patients (83%) had near complete resolution of aorto-iliac thrombus after 12 to 72 hours of thrombolysis to reveal underlying stenoses. The remaining patient's thrombolysis therapy was cut short at 48 hours due to behavioral issues, but had enough clearing of juxtarenal thrombus to undergo placement of aorto-iliac endografts. There were no perioperative deaths, myocardial infarctions, strokes or major complications. Temporary laboratory abnormalities (coagulopathy and/or increase in serum creatinine) were seen in four patients (67%), but all resolved by discharge without clinical sequelae. The primary patency is 100% at early follow-up of up to 15 months.</p><p><strong>Conclusions: </strong>In the setting of chronic juxtarenal aortic occlusions, thrombolysis can provide effective clearing of the juxtarenal aortic thrombus to allow safe definitive therapy with aorto-iliac endografts. The approach deserves consideration in patients at high risk for open reconstruction.</p>","PeriodicalId":50245,"journal":{"name":"Journal of Cardiovascular Surgery","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23736/S0021-9509.23.12685-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The purpose of this study was to review early experience with catheter directed thrombolysis in the setting of chronic juxtarenal aortic occlusion as an initial therapy to allow safe definitive management with placement of aorto-iliac endografts.

Methods: A retrospective review was performed of all patients with a diagnosis of chronic juxtarenal aortic occlusion treated by the author with initial catheter directed thrombolysis. In all, six patients (five males and one female, average age of 57 years) treated between 2019 and 2022 met criteria. Total duration of symptoms prior to thrombolysis ranged from 2 to 54 months (average 23 months.) Four patients (67%) had progressed to tissue loss 2 to 5 months prior to the initiation of thrombolysis (average 3.25 months). Radiographic confirmation of aortic occlusion on preoperative imaging was noted 7 to 846 days prior to the initiation of thrombolysis (average 190 days).

Results: Five of six patients (83%) had near complete resolution of aorto-iliac thrombus after 12 to 72 hours of thrombolysis to reveal underlying stenoses. The remaining patient's thrombolysis therapy was cut short at 48 hours due to behavioral issues, but had enough clearing of juxtarenal thrombus to undergo placement of aorto-iliac endografts. There were no perioperative deaths, myocardial infarctions, strokes or major complications. Temporary laboratory abnormalities (coagulopathy and/or increase in serum creatinine) were seen in four patients (67%), but all resolved by discharge without clinical sequelae. The primary patency is 100% at early follow-up of up to 15 months.

Conclusions: In the setting of chronic juxtarenal aortic occlusions, thrombolysis can provide effective clearing of the juxtarenal aortic thrombus to allow safe definitive therapy with aorto-iliac endografts. The approach deserves consideration in patients at high risk for open reconstruction.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
慢性肾旁主动脉闭塞的主动脉分叉溶解和覆盖血管内重建(LA CERAB)技术。
背景:本研究的目的是回顾导管定向溶栓治疗慢性肾旁主动脉阻塞的早期经验,作为初始治疗,通过放置主动脉-髂内移植物进行安全的最终治疗。方法:回顾性分析所有诊断为慢性肾旁主动脉阻塞的患者,这些患者最初接受导管定向溶栓治疗。在2019年至2022年期间接受治疗的6名患者(5名男性和1名女性,平均年龄57岁)符合标准。溶栓前症状的总持续时间为2至54个月(平均23个月)。4例患者(67%)在开始溶栓治疗前2 - 5个月进展为组织丢失(平均3.25个月)。在开始溶栓前7 ~ 846天(平均190天),术前影像学证实主动脉闭塞。结果:6例患者中有5例(83%)在溶栓12至72小时后主动脉-髂血栓接近完全溶解,显示出潜在的狭窄。由于行为问题,其余患者的溶栓治疗在48小时后被缩短,但肾旁血栓清除足够,可以进行主动脉-髂内移植物的放置。无围手术期死亡、心肌梗死、中风或主要并发症。4例患者(67%)出现暂时性实验室异常(凝血功能障碍和/或血清肌酐升高),但均在出院时消退,无临床后遗症。早期随访15个月,原发性通畅率为100%。结论:在慢性肾旁主动脉闭塞的情况下,溶栓可以有效清除肾旁主动脉血栓,使主动脉-髂内移植物安全可靠地进行治疗。对于开放性重建的高危患者,该方法值得考虑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.50
自引率
7.10%
发文量
204
审稿时长
4-8 weeks
期刊介绍: The Journal of Cardiovascular Surgery publishes scientific papers on cardiac, thoracic and vascular surgery. Manuscripts may be submitted in the form of editorials, original articles, review articles, case reports, therapeutical notes, special articles and letters to the Editor. Manuscripts are expected to comply with the instructions to authors which conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Editors by the International Committee of Medical Journal Editors (www.icmje.org). Articles not conforming to international standards will not be considered for acceptance.
期刊最新文献
Subclavian artery revascularization with subclavian-carotid transposition for TEVAR and non-TEVAR patients. Current perspectives in acute type B aortic dissections: a literature review. Long-term outcomes of thoracic endovascular aortic repair for the treatment of descending thoracic aortic aneurysms: a systematic review and meta-analysis. Outcomes of Omniflow® II prosthesis used for revascularization in the femoral tract both in infected and non-infected setting. Frozen elephant trunk technique for aortic arch surgery: the Bordeaux University Hospital experience with Thoraflex hybrid prosthesis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1